Evidence map›Paper›PMID 26482604›Full record

ArticleBMC systems biology2015

Conditional robustness analysis for fragility discovery and target identification in biochemical networks and in cancer systems biology.

Fortunato Bianconi, Elisa Baldelli, Vienna Ludovini, Vienna Luovini, Emanuel F Petricoin, Lucio Crinò, Paolo Valigi

Erratum issuedOpen access · diamondAbstract read
In one paragraph

Article in BMC systems biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Fortunato BianconiDept of Experimental Medicine, University of Perugia, Polo Unico Sant'Andrea delle Fratte, Via Gambuli, 1, Perugia, 06156, IT. fortunato.bianconi@unipg.it.
Elisa BaldelliCenter for Applied Proteomics and Molecular Medicine George Mason University, 10900 University Blvd, Manassas, 20110, USA. ebaldell@gmu.edu.
Vienna Ludovini
Vienna LuoviniDept of Medical Oncology, Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Piazzale Menghini, 1, Loc. Sant'Andrea delle Fratte, Perugia, 06156, IT. ludoviniv@hotmail.com.
Emanuel F PetricoinCenter for Applied Proteomics and Molecular Medicine George Mason University, 10900 University Blvd, Manassas, 20110, USA. epetrico@gmu.edu.
Lucio CrinòDept of Medical Oncology, Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Piazzale Menghini, 1, Loc. Sant'Andrea delle Fratte, Perugia, 06156, IT. luciocrino@unipg.it.
Paolo ValigiDept of Engineering, University of Perugia, G. Duranti, 93, Perugia, 06125, IT. luciocrino@unipg.it.
Azienda Ospedaliera di Perugia · ITGeorge Mason University · USUniversity of Perugia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe study of cancer therapy is a key issue in the field of oncology research and the development of target therapies is one of the main problems currently under investigation. This is particularly relevant in different types of tumor where traditional chemotherapy approaches often fail, such as lung cancer.

resultsWe started from the general definition of robustness introduced by Kitano and applied it to the analysis of dynamical biochemical networks, proposing a new algorithm based on moment independent analysis of input/output uncertainty. The framework utilizes novel computational methods which enable evaluating the model fragility with respect to quantitative performance measures and parameters such as reaction rate constants and initial conditions. The algorithm generates a small subset of parameters that can be used to act on complex networks and to obtain the desired behaviors. We have applied the proposed framework to the EGFR-IGF1R signal transduction network, a crucial pathway in lung cancer, as an example of Cancer Systems Biology application in drug discovery. Furthermore, we have tested our framework on a pulse generator network as an example of Synthetic Biology application, thus proving the suitability of our methodology to the characterization of the input/output synthetic circuits.

conclusionsThe achieved results are of immediate practical application in computational biology, and while we demonstrate their use in two specific examples, they can in fact be used to study a wider class of biological systems.

Indexed as

Models, TheoreticalAlgorithmsComputational BiologyDrug DiscoveryErbB ReceptorsFeedback, PhysiologicalHumansLung NeoplasmsMetabolic Networks and PathwaysReceptor, IGF Type 1Receptors, SomatomedinSignal TransductionSynthetic BiologySystems BiologyUncertaintyEGFR protein, humanErbB ReceptorsIGF1R protein, humanReceptor, IGF Type 1Receptors, Somatomedin

Identifiers

PMID26482604
PMCPMC4617482
OpenAlexW2105394052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.